543 related articles for article (PubMed ID: 22684647)
21. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.
Song JH; Cha SH; Hong SB; Kim DH
J Hypertens Suppl; 2006 Mar; 24(1):S101-6. PubMed ID: 16601562
[TBL] [Abstract][Full Text] [Related]
22. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.
Remuzzi G; Perico N; Macia M; Ruggenenti P
Kidney Int Suppl; 2005 Dec; (99):S57-65. PubMed ID: 16336578
[TBL] [Abstract][Full Text] [Related]
23. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
24. Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
Laverman GD; de Zeeuw D; Navis G
J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):205-13. PubMed ID: 12584664
[TBL] [Abstract][Full Text] [Related]
25. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
26. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
27. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL; Townsend RR
J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
[TBL] [Abstract][Full Text] [Related]
28. Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition.
Alfie J; Aparicio LS; Waisman GD
Rev Recent Clin Trials; 2011 May; 6(2):134-46. PubMed ID: 21241234
[TBL] [Abstract][Full Text] [Related]
29. Dual RAAS blockade is desirable in kidney disease: con.
Bakris GL
Kidney Int; 2010 Sep; 78(6):546-9. PubMed ID: 20664560
[TBL] [Abstract][Full Text] [Related]
30. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
31. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
32. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
Schleich F; Krzesinski JM; Piérard L; Scheen AJ
Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
[TBL] [Abstract][Full Text] [Related]
33. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
34. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic measures in proteinuric nephropathy.
Praga M
Kidney Int Suppl; 2005 Dec; (99):S137-41. PubMed ID: 16336567
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
Zaffanello M; Franchini M; Fanos V
Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
[TBL] [Abstract][Full Text] [Related]
38. Update on role of direct renin inhibitor in diabetic kidney disease.
Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
[TBL] [Abstract][Full Text] [Related]
39. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
40. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
Jorde UP
Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]